NCT01946633

Brief Summary

The present study is a feasibility study to assess the safety and efficacy of wireless capsule endoscope and compare the data obtained with those obtained by using a conventional esophagogastroduodenoscopy. The product was developed and manufacture in China.(the NaviCam. AKC-1.China)

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 12, 2013

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 19, 2013

Completed
12 days until next milestone

Study Start

First participant enrolled

October 1, 2013

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2014

Completed
Last Updated

October 30, 2013

Status Verified

October 1, 2013

Enrollment Period

11 months

First QC Date

September 12, 2013

Last Update Submit

October 28, 2013

Conditions

Outcome Measures

Primary Outcomes (2)

  • the percentage of complete visualization of anatomic landmarks

    the percentage of patients in whom there was complete visualization of the gastric surface in the antrum, body, and fundus and identification of the cardia and pylorus

    2 year

  • examination time and the percentage of abnormal finding

    examination time and the percentage of abnormal findings seen on gastroscopy that were reproducible by capsule endoscopy

    2 year

Secondary Outcomes (2)

  • adverse effect

    2 year

  • Acceptability

    2 year

Study Arms (1)

Esophagogastroduodenoscopy(ECG)

EXPERIMENTAL

n=15

Device: magnetic-controlled capsule endoscopy(Navicam)

Interventions

Esophagogastroduodenoscopy(ECG)

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • upper abdominal symptoms (≥1 year )
  • surveillance gastroscopy for known gastric ulcer or polyps
  • history of gastric ulcer or polyps (≤1w)at Nanfang Hospital were enrolled.

You may not qualify if:

  • dysphagia
  • suspected or documented digestive tract malformation ,obstruction, strictures or fistula
  • acute upper GI bleeding, acute enteritis, acute ischemia disease
  • history of abdominal operations
  • impaired renal function, congestive heart failure
  • patients with critical condition or mental illness
  • patients with, known allergy to polymer material or antifoam agent
  • patients with cardiac pacemakers or other implanted electromedical devices,magnetic resonance imaging ( mri) examination in 7 days
  • pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Departement of Gastroenterology, Nanfang Hospital, Southern Medical University

Guangzhou, Guangdong, 510515, China

RECRUITING

Related Publications (1)

  • Keller J, Fibbe C, Volke F, Gerber J, Mosse AC, Reimann-Zawadzki M, Rabinovitz E, Layer P, Schmitt D, Andresen V, Rosien U, Swain P. Inspection of the human stomach using remote-controlled capsule endoscopy: a feasibility study in healthy volunteers (with videos). Gastrointest Endosc. 2011 Jan;73(1):22-8. doi: 10.1016/j.gie.2010.08.053. Epub 2010 Nov 9.

    PMID: 21067740BACKGROUND

Related Links

MeSH Terms

Conditions

Stomach UlcerPolyposis, Gastric

Condition Hierarchy (Ancestors)

Peptic UlcerDuodenal DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesStomach Diseases

Central Study Contacts

xinying Wang, Associate Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

September 12, 2013

First Posted

September 19, 2013

Study Start

October 1, 2013

Primary Completion

September 1, 2014

Last Updated

October 30, 2013

Record last verified: 2013-10

Locations